Concepts (140)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proto-Oncogene Proteins | 10 | 2024 | 2618 | 2.200 |
Why?
|
| 5-Methylcytosine | 6 | 2023 | 59 | 1.650 |
Why?
|
| DNA-Binding Proteins | 10 | 2024 | 4992 | 1.420 |
Why?
|
| Pluripotent Stem Cells | 3 | 2020 | 100 | 1.240 |
Why?
|
| Cell Differentiation | 10 | 2023 | 4104 | 0.980 |
Why?
|
| Octamer Transcription Factor-3 | 3 | 2020 | 105 | 0.930 |
Why?
|
| DNA Methylation | 8 | 2024 | 2768 | 0.850 |
Why?
|
| Folic Acid | 1 | 2024 | 370 | 0.790 |
Why?
|
| Cell Lineage | 3 | 2020 | 697 | 0.740 |
Why?
|
| Neural Tube Defects | 1 | 2024 | 373 | 0.730 |
Why?
|
| Embryonic Development | 3 | 2024 | 313 | 0.710 |
Why?
|
| DNA Demethylation | 1 | 2020 | 11 | 0.700 |
Why?
|
| beta Catenin | 1 | 2023 | 687 | 0.660 |
Why?
|
| Germ Layers | 4 | 2023 | 17 | 0.600 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2020 | 223 | 0.580 |
Why?
|
| Embryonic Stem Cells | 5 | 2017 | 277 | 0.580 |
Why?
|
| Cytosine | 3 | 2013 | 155 | 0.520 |
Why?
|
| Gene Expression Regulation, Developmental | 5 | 2024 | 1491 | 0.460 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2015 | 256 | 0.460 |
Why?
|
| Brain | 2 | 2024 | 4202 | 0.430 |
Why?
|
| Endoderm | 2 | 2023 | 56 | 0.350 |
Why?
|
| Mice | 15 | 2024 | 35421 | 0.340 |
Why?
|
| Promoter Regions, Genetic | 2 | 2015 | 3205 | 0.310 |
Why?
|
| Animals | 18 | 2024 | 61357 | 0.290 |
Why?
|
| Arteries | 2 | 2006 | 288 | 0.270 |
Why?
|
| Mixed Function Oxygenases | 2 | 2024 | 70 | 0.260 |
Why?
|
| Forkhead Transcription Factors | 1 | 2009 | 762 | 0.250 |
Why?
|
| DNA | 2 | 2009 | 3041 | 0.230 |
Why?
|
| Epigenesis, Genetic | 3 | 2024 | 1439 | 0.230 |
Why?
|
| Interferon-gamma | 2 | 2006 | 1169 | 0.220 |
Why?
|
| Nitric Oxide Synthase | 1 | 2004 | 328 | 0.220 |
Why?
|
| Transcription Factor 7-Like 1 Protein | 1 | 2023 | 30 | 0.220 |
Why?
|
| Urinary Incontinence, Stress | 1 | 2023 | 45 | 0.210 |
Why?
|
| Automobile Driving | 1 | 2023 | 32 | 0.210 |
Why?
|
| Mice, Inbred C57BL | 4 | 2020 | 7052 | 0.210 |
Why?
|
| Pregnancy | 4 | 2024 | 7916 | 0.210 |
Why?
|
| Urethra | 1 | 2023 | 167 | 0.210 |
Why?
|
| Transplantation, Homologous | 2 | 2006 | 3048 | 0.190 |
Why?
|
| Endothelial Cells | 2 | 2023 | 1031 | 0.180 |
Why?
|
| Wnt Signaling Pathway | 1 | 2023 | 443 | 0.180 |
Why?
|
| Genomics | 2 | 2023 | 2832 | 0.180 |
Why?
|
| Endothelium, Vascular | 1 | 2004 | 863 | 0.170 |
Why?
|
| Uterine Diseases | 1 | 2019 | 38 | 0.170 |
Why?
|
| Epigenomics | 1 | 2020 | 271 | 0.150 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2019 | 492 | 0.150 |
Why?
|
| Cellular Reprogramming | 1 | 2020 | 203 | 0.150 |
Why?
|
| Transcription Factors | 3 | 2020 | 5415 | 0.140 |
Why?
|
| Ectoderm | 1 | 2017 | 64 | 0.140 |
Why?
|
| Gastrula | 1 | 2017 | 62 | 0.140 |
Why?
|
| CpG Islands | 3 | 2015 | 669 | 0.140 |
Why?
|
| Crosses, Genetic | 1 | 2017 | 251 | 0.140 |
Why?
|
| Telomere Homeostasis | 1 | 2017 | 77 | 0.140 |
Why?
|
| Catalysis | 1 | 2017 | 245 | 0.140 |
Why?
|
| Embryo, Mammalian | 1 | 2020 | 744 | 0.140 |
Why?
|
| Organoids | 1 | 2019 | 329 | 0.130 |
Why?
|
| Gene Knockout Techniques | 1 | 2017 | 267 | 0.130 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2017 | 114 | 0.130 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2017 | 125 | 0.130 |
Why?
|
| Dioxygenases | 3 | 2013 | 172 | 0.130 |
Why?
|
| Binding Sites | 2 | 2011 | 2249 | 0.130 |
Why?
|
| T-Lymphocytes | 3 | 2006 | 3945 | 0.130 |
Why?
|
| Transcription Initiation Site | 1 | 2015 | 48 | 0.120 |
Why?
|
| Gene Deletion | 1 | 2020 | 1471 | 0.120 |
Why?
|
| Mice, Knockout | 1 | 2024 | 5692 | 0.120 |
Why?
|
| NIH 3T3 Cells | 1 | 2015 | 254 | 0.120 |
Why?
|
| Oxidation-Reduction | 2 | 2013 | 697 | 0.120 |
Why?
|
| Chromatin | 1 | 2020 | 1043 | 0.120 |
Why?
|
| Cells, Cultured | 2 | 2020 | 5657 | 0.120 |
Why?
|
| Cell Line | 4 | 2017 | 5313 | 0.120 |
Why?
|
| Gene Dosage | 1 | 2017 | 822 | 0.110 |
Why?
|
| Sequence Deletion | 1 | 2017 | 908 | 0.110 |
Why?
|
| Hydroxylation | 2 | 2010 | 58 | 0.110 |
Why?
|
| HEK293 Cells | 2 | 2015 | 1458 | 0.110 |
Why?
|
| Gestational Age | 1 | 2017 | 1160 | 0.110 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 4202 | 0.100 |
Why?
|
| Transcriptome | 1 | 2020 | 1959 | 0.090 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2013 | 294 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 2 | 2013 | 1469 | 0.090 |
Why?
|
| Blastocyst | 2 | 2023 | 138 | 0.090 |
Why?
|
| Consensus Sequence | 1 | 2009 | 117 | 0.090 |
Why?
|
| Endometrial Neoplasms | 1 | 2019 | 1386 | 0.090 |
Why?
|
| Mutant Proteins | 1 | 2010 | 233 | 0.090 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2011 | 506 | 0.080 |
Why?
|
| Genome | 1 | 2013 | 689 | 0.080 |
Why?
|
| Tandem Repeat Sequences | 1 | 2009 | 203 | 0.080 |
Why?
|
| Teratoma | 1 | 2011 | 248 | 0.080 |
Why?
|
| Structure-Activity Relationship | 1 | 2009 | 975 | 0.070 |
Why?
|
| Base Sequence | 2 | 2013 | 5405 | 0.070 |
Why?
|
| Point Mutation | 1 | 2009 | 785 | 0.070 |
Why?
|
| Transcription, Genetic | 1 | 2015 | 3328 | 0.070 |
Why?
|
| Amino Acid Sequence | 2 | 2009 | 4532 | 0.070 |
Why?
|
| Transplantation, Heterologous | 2 | 2006 | 1051 | 0.060 |
Why?
|
| Humans | 12 | 2024 | 270713 | 0.060 |
Why?
|
| Histones | 1 | 2013 | 1512 | 0.060 |
Why?
|
| Female | 5 | 2024 | 148885 | 0.060 |
Why?
|
| Molecular Sequence Data | 2 | 2009 | 6639 | 0.060 |
Why?
|
| Cyclosporine | 1 | 2006 | 293 | 0.060 |
Why?
|
| Signal Transduction | 2 | 2020 | 12042 | 0.060 |
Why?
|
| Computational Biology | 1 | 2011 | 1295 | 0.060 |
Why?
|
| Arteriosclerosis | 1 | 2004 | 177 | 0.060 |
Why?
|
| Mice, SCID | 2 | 2006 | 1825 | 0.060 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2004 | 262 | 0.060 |
Why?
|
| Protein Binding | 1 | 2009 | 3472 | 0.050 |
Why?
|
| Antigen Presentation | 1 | 2004 | 286 | 0.050 |
Why?
|
| Parturition | 1 | 2023 | 60 | 0.050 |
Why?
|
| Repressor Proteins | 1 | 2009 | 1716 | 0.050 |
Why?
|
| Sirolimus | 1 | 2006 | 829 | 0.050 |
Why?
|
| Cell Communication | 1 | 2004 | 509 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2004 | 1044 | 0.040 |
Why?
|
| Lymphocyte Activation | 1 | 2004 | 1719 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2023 | 2140 | 0.040 |
Why?
|
| Cell Cycle | 1 | 2023 | 2134 | 0.040 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2010 | 3155 | 0.040 |
Why?
|
| Angiopoietin-1 | 1 | 2017 | 20 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 2019 | 573 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2023 | 1580 | 0.030 |
Why?
|
| Endometrium | 1 | 2019 | 457 | 0.030 |
Why?
|
| Rats | 1 | 2023 | 6397 | 0.030 |
Why?
|
| U937 Cells | 1 | 2013 | 178 | 0.030 |
Why?
|
| Catalytic Domain | 1 | 2013 | 306 | 0.020 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2013 | 271 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2023 | 5145 | 0.020 |
Why?
|
| Biocatalysis | 1 | 2010 | 64 | 0.020 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2010 | 7273 | 0.020 |
Why?
|
| Caspases | 1 | 2013 | 672 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2023 | 7317 | 0.020 |
Why?
|
| Male | 1 | 2020 | 128479 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2013 | 1801 | 0.020 |
Why?
|
| Dinucleoside Phosphates | 1 | 2009 | 25 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2013 | 2087 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2009 | 866 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2009 | 721 | 0.020 |
Why?
|
| Biomarkers | 1 | 2017 | 5048 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 2010 | 1958 | 0.020 |
Why?
|
| RNA Interference | 1 | 2009 | 1381 | 0.010 |
Why?
|
| Transfection | 1 | 2009 | 3109 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2006 | 709 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2006 | 1436 | 0.010 |
Why?
|
| Cell Movement | 1 | 2004 | 2468 | 0.010 |
Why?
|
| Mutation | 1 | 2010 | 15917 | 0.010 |
Why?
|